An AI-based diabetic retinopathy screening system and its us | 52407
International Research Journals
Reach Us +44 330 818 7254

An AI-based diabetic retinopathy screening system and its use in real-world clinical settings in Australia and Singapore


Tan Teck Jack

The World Health Organization announced in 2018 that 422 million people worldwide suffer from diabetes mellitus. The projected impact of vision impairment and blindness caused by Diabetic Retinopathy (DR) will result in significant public health and economic consequences. DR is preventable and treatable if detected early through an annual eye screening. However, screening rates are low globally due to a paucity of trained eye-health professionals in developing countries and in rural or remote areas of developed countries. Based on the research from CSIRO Australian e-Health Research Centre, TeleMedC group commercialized an AIbased Diabetic Retinopathy screening system-DR grader, an automated DR grading and preliminary referral decision support tool for patients with diabetes. The cloud-based tele-ophthalmology system has the functionalities of: (1) Deep learning based image quality assessment tool; (2) Deep learning based DR “disease/no disease” grading for color retinal images; (3) DR lesion localization and DR level indication; (4) Preliminary report of patient referral/no referral decision; and (5) DR disease audit by eye experts and developing patient referral pathway. DR grader has been deployed in a GP Super clinic at Midland, Western Australia from December 2016 onwards.

Share this article